{"id":1462,"date":"2023-12-23T21:09:19","date_gmt":"2023-12-23T21:09:19","guid":{"rendered":"https:\/?p=1462"},"modified":"2023-12-23T21:12:41","modified_gmt":"2023-12-23T21:12:41","slug":"symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy","status":"publish","type":"post","link":"https:\/\/eutranslationalmedicine.org\/orc\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\/","title":{"rendered":"Symposium: Emerging treatment options for metastatic hormone-sensitive prostate cancer (mHSPC); Understanding combination anti-androgen therapy and androgen deprivation therapy"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

Presented at the 9th Annual EUSTM Congress on Immunotherapeutics \u2013 From Biology to Patient Care<\/p>\n","protected":false},"author":1,"featured_media":1464,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[28,23],"tags":[],"class_list":["post-1462","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer-therapeutics","category-immuno-oncology"],"acf":[],"yoast_head":"\nSymposium: Emerging treatment options for metastatic hormone-sensitive prostate cancer (mHSPC); Understanding combination anti-androgen therapy and androgen deprivation therapy - Oncology Resource Center<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eutranslationalmedicine.org\/orc\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Symposium: Emerging treatment options for metastatic hormone-sensitive prostate cancer (mHSPC); Understanding combination anti-androgen therapy and androgen deprivation therapy\" \/>\n<meta property=\"og:description\" content=\"Presented at the 9th Annual EUSTM Congress on Immunotherapeutics \u2013 From Biology to Patient Care\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eutranslationalmedicine.org\/orc\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"Oncology Resource Center\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/groups\/eustm\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-23T21:09:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-23T21:12:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/eutranslationalmedicine.org\/orc\/wp-content\/uploads\/2023\/12\/10124275_193-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"oncology\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@OfficialEustm\" \/>\n<meta name=\"twitter:site\" content=\"@OfficialEustm\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"oncology\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\\\/\"},\"author\":{\"name\":\"oncology\",\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/#\\\/schema\\\/person\\\/1fda2b101de11642c98f61c36c2e22bd\"},\"headline\":\"Symposium: Emerging treatment options for metastatic hormone-sensitive prostate cancer (mHSPC); Understanding combination anti-androgen therapy and androgen deprivation therapy\",\"datePublished\":\"2023-12-23T21:09:19+00:00\",\"dateModified\":\"2023-12-23T21:12:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\\\/\"},\"wordCount\":18,\"publisher\":{\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/10124275_193-scaled.jpg\",\"articleSection\":[\"Cancer Therapeutics\",\"Immuno-Oncology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\\\/\",\"url\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\\\/\",\"name\":\"Symposium: Emerging treatment options for metastatic hormone-sensitive prostate cancer (mHSPC); Understanding combination anti-androgen therapy and androgen deprivation therapy - Oncology Resource Center\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/10124275_193-scaled.jpg\",\"datePublished\":\"2023-12-23T21:09:19+00:00\",\"dateModified\":\"2023-12-23T21:12:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/10124275_193-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/10124275_193-scaled.jpg\",\"width\":2560,\"height\":2560},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Symposium: Emerging treatment options for metastatic hormone-sensitive prostate cancer (mHSPC); Understanding combination anti-androgen therapy and androgen deprivation therapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/#website\",\"url\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/\",\"name\":\"Oncology Resource Center (ORC)\",\"description\":\"Connect with the Pioneers of Oncology \u2013 Webcasts, Webinars, and More at Your Fingertips\",\"publisher\":{\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/#organization\"},\"alternateName\":\"ORC\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/#organization\",\"name\":\"European Society for Translational Medicine (EUSTM)\",\"alternateName\":\"EUSTM\",\"url\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/12316116_861128363985317_2765353276972680036_n.png\",\"contentUrl\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/12316116_861128363985317_2765353276972680036_n.png\",\"width\":800,\"height\":800,\"caption\":\"European Society for Translational Medicine (EUSTM)\"},\"image\":{\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/groups\\\/eustm\",\"https:\\\/\\\/x.com\\\/OfficialEustm\",\"https:\\\/\\\/www.linkedin.com\\\/groups\\\/European-Society-Translational-Medicine-EUSTM-4690712\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/#\\\/schema\\\/person\\\/1fda2b101de11642c98f61c36c2e22bd\",\"name\":\"oncology\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/32f3937ccd4f3d049a1b282bd013efd20a21516070c0aaea8321707c48f63d0a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/32f3937ccd4f3d049a1b282bd013efd20a21516070c0aaea8321707c48f63d0a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/32f3937ccd4f3d049a1b282bd013efd20a21516070c0aaea8321707c48f63d0a?s=96&d=mm&r=g\",\"caption\":\"oncology\"},\"sameAs\":[\"https:\"],\"url\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/orc\\\/author\\\/oncology\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Symposium: Emerging treatment options for metastatic hormone-sensitive prostate cancer (mHSPC); Understanding combination anti-androgen therapy and androgen deprivation therapy - Oncology Resource Center","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eutranslationalmedicine.org\/orc\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\/","og_locale":"en_US","og_type":"article","og_title":"Symposium: Emerging treatment options for metastatic hormone-sensitive prostate cancer (mHSPC); Understanding combination anti-androgen therapy and androgen deprivation therapy","og_description":"Presented at the 9th Annual EUSTM Congress on Immunotherapeutics \u2013 From Biology to Patient Care","og_url":"https:\/\/eutranslationalmedicine.org\/orc\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\/","og_site_name":"Oncology Resource Center","article_publisher":"https:\/\/www.facebook.com\/groups\/eustm","article_published_time":"2023-12-23T21:09:19+00:00","article_modified_time":"2023-12-23T21:12:41+00:00","og_image":[{"width":2560,"height":2560,"url":"https:\/\/eutranslationalmedicine.org\/orc\/wp-content\/uploads\/2023\/12\/10124275_193-scaled.jpg","type":"image\/jpeg"}],"author":"oncology","twitter_card":"summary_large_image","twitter_creator":"@OfficialEustm","twitter_site":"@OfficialEustm","twitter_misc":{"Written by":"oncology","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/eutranslationalmedicine.org\/orc\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\/#article","isPartOf":{"@id":"https:\/\/eutranslationalmedicine.org\/orc\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\/"},"author":{"name":"oncology","@id":"https:\/\/eutranslationalmedicine.org\/orc\/#\/schema\/person\/1fda2b101de11642c98f61c36c2e22bd"},"headline":"Symposium: Emerging treatment options for metastatic hormone-sensitive prostate cancer (mHSPC); Understanding combination anti-androgen therapy and androgen deprivation therapy","datePublished":"2023-12-23T21:09:19+00:00","dateModified":"2023-12-23T21:12:41+00:00","mainEntityOfPage":{"@id":"https:\/\/eutranslationalmedicine.org\/orc\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\/"},"wordCount":18,"publisher":{"@id":"https:\/\/eutranslationalmedicine.org\/orc\/#organization"},"image":{"@id":"https:\/\/eutranslationalmedicine.org\/orc\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/eutranslationalmedicine.org\/orc\/wp-content\/uploads\/2023\/12\/10124275_193-scaled.jpg","articleSection":["Cancer Therapeutics","Immuno-Oncology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/eutranslationalmedicine.org\/orc\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\/","url":"https:\/\/eutranslationalmedicine.org\/orc\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\/","name":"Symposium: Emerging treatment options for metastatic hormone-sensitive prostate cancer (mHSPC); Understanding combination anti-androgen therapy and androgen deprivation therapy - Oncology Resource Center","isPartOf":{"@id":"https:\/\/eutranslationalmedicine.org\/orc\/#website"},"primaryImageOfPage":{"@id":"https:\/\/eutranslationalmedicine.org\/orc\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\/#primaryimage"},"image":{"@id":"https:\/\/eutranslationalmedicine.org\/orc\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/eutranslationalmedicine.org\/orc\/wp-content\/uploads\/2023\/12\/10124275_193-scaled.jpg","datePublished":"2023-12-23T21:09:19+00:00","dateModified":"2023-12-23T21:12:41+00:00","breadcrumb":{"@id":"https:\/\/eutranslationalmedicine.org\/orc\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eutranslationalmedicine.org\/orc\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/eutranslationalmedicine.org\/orc\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\/#primaryimage","url":"https:\/\/eutranslationalmedicine.org\/orc\/wp-content\/uploads\/2023\/12\/10124275_193-scaled.jpg","contentUrl":"https:\/\/eutranslationalmedicine.org\/orc\/wp-content\/uploads\/2023\/12\/10124275_193-scaled.jpg","width":2560,"height":2560},{"@type":"BreadcrumbList","@id":"https:\/\/eutranslationalmedicine.org\/orc\/symposium-emerging-treatment-options-for-metastatic-hormone-sensitive-prostate-cancer-mhspc-understanding-combination-anti-androgen-therapy-and-androgen-deprivation-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/eutranslationalmedicine.org\/orc\/"},{"@type":"ListItem","position":2,"name":"Symposium: Emerging treatment options for metastatic hormone-sensitive prostate cancer (mHSPC); Understanding combination anti-androgen therapy and androgen deprivation therapy"}]},{"@type":"WebSite","@id":"https:\/\/eutranslationalmedicine.org\/orc\/#website","url":"https:\/\/eutranslationalmedicine.org\/orc\/","name":"Oncology Resource Center (ORC)","description":"Connect with the Pioneers of Oncology \u2013 Webcasts, Webinars, and More at Your Fingertips","publisher":{"@id":"https:\/\/eutranslationalmedicine.org\/orc\/#organization"},"alternateName":"ORC","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eutranslationalmedicine.org\/orc\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/eutranslationalmedicine.org\/orc\/#organization","name":"European Society for Translational Medicine (EUSTM)","alternateName":"EUSTM","url":"https:\/\/eutranslationalmedicine.org\/orc\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/eutranslationalmedicine.org\/orc\/#\/schema\/logo\/image\/","url":"https:\/\/eutranslationalmedicine.org\/orc\/wp-content\/uploads\/2024\/01\/12316116_861128363985317_2765353276972680036_n.png","contentUrl":"https:\/\/eutranslationalmedicine.org\/orc\/wp-content\/uploads\/2024\/01\/12316116_861128363985317_2765353276972680036_n.png","width":800,"height":800,"caption":"European Society for Translational Medicine (EUSTM)"},"image":{"@id":"https:\/\/eutranslationalmedicine.org\/orc\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/groups\/eustm","https:\/\/x.com\/OfficialEustm","https:\/\/www.linkedin.com\/groups\/European-Society-Translational-Medicine-EUSTM-4690712"]},{"@type":"Person","@id":"https:\/\/eutranslationalmedicine.org\/orc\/#\/schema\/person\/1fda2b101de11642c98f61c36c2e22bd","name":"oncology","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/32f3937ccd4f3d049a1b282bd013efd20a21516070c0aaea8321707c48f63d0a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/32f3937ccd4f3d049a1b282bd013efd20a21516070c0aaea8321707c48f63d0a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/32f3937ccd4f3d049a1b282bd013efd20a21516070c0aaea8321707c48f63d0a?s=96&d=mm&r=g","caption":"oncology"},"sameAs":["https:"],"url":"https:\/\/eutranslationalmedicine.org\/orc\/author\/oncology\/"}]}},"_links":{"self":[{"href":"https:\/\/eutranslationalmedicine.org\/orc\/wp-json\/wp\/v2\/posts\/1462","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eutranslationalmedicine.org\/orc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eutranslationalmedicine.org\/orc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eutranslationalmedicine.org\/orc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eutranslationalmedicine.org\/orc\/wp-json\/wp\/v2\/comments?post=1462"}],"version-history":[{"count":1,"href":"https:\/\/eutranslationalmedicine.org\/orc\/wp-json\/wp\/v2\/posts\/1462\/revisions"}],"predecessor-version":[{"id":1465,"href":"https:\/\/eutranslationalmedicine.org\/orc\/wp-json\/wp\/v2\/posts\/1462\/revisions\/1465"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eutranslationalmedicine.org\/orc\/wp-json\/wp\/v2\/media\/1464"}],"wp:attachment":[{"href":"https:\/\/eutranslationalmedicine.org\/orc\/wp-json\/wp\/v2\/media?parent=1462"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eutranslationalmedicine.org\/orc\/wp-json\/wp\/v2\/categories?post=1462"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eutranslationalmedicine.org\/orc\/wp-json\/wp\/v2\/tags?post=1462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}